@article{article, title  = {{RANGE: A randomized, double-blind, placebo-controlled phase 3 study of docetaxel (DOC) with or without ramucirumab (RAM) in platinum-refractory advanced or metastatic urothelial carcinoma}},

 publisher = {{Elsevier BV}},

 url = {{https://doi.org/10.1093/annonc/mdx440.028 }},

 year = {{2017}},

 month = {{9}},

 author = {{Petrylak DP and Chi KN and Drakaki A and Sternberg CN and de Wit R and Nishiyama H and Yu EY and Castellano D and Hussain S and Percent IJ and Fléchon A et al}},

 doi = {{10.1093/annonc/mdx440.028}},

 volume = {{28}},

 journal = {{Annals of Oncology}},

 pages = {{v621-v621}},

 note = {{Accessed on 2025/12/05}}}